Krishana Phoschem Ltd
Krishana Phoschem Ltd
ChemicalsKey Fundamentals
MicrocapFertilizersChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Krishana Phoschem Ltd insights
47 extracted metrics + investor summaries across FY14–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company is expected to give good quarter
- Company has delivered good profit growth of 55.9% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.0%
- Company's median sales growth is 33.6% of last 10 years
Weaknesses
2- Stock is trading at 10.3 times its book value
- Company might be capitalizing the interest cost
Growth Rate
AI Analysis — Bull vs Bear
Krishana Phoschem Ltd is a chemicals company with a market cap of ₹5,609 Cr trading at a P/E of 28.3x and P/B of 9.93x. The company has delivered exceptional profit growth of 95% TTM and 89% CAGR over 3 years, with ROE expanding to 38% in the last year, though its valuation multiples are elevated relative to book value.
- TTM compounded profit growth of 95% demonstrates strong earnings momentum
- 3-year compounded profit CAGR of 89% shows sustained high growth trajectory
- Last year ROE of 38% is significantly above the 3-year average of 28%, indicating improving capital efficiency
- TTM sales growth of 73% signals robust top-line expansion and strong demand
- 5-year compounded sales CAGR of 67% reflects consistent revenue scaling over a longer period
- 10-year median sales growth of 33.6% indicates a long track record of above-average organic growth
- Stock CAGR of 61% over 1 year and 60% over 3 years shows consistent investor re-rating alongside fundamentals
- 5-year profit CAGR of 55.9% well above typical chemical sector peers suggests structural competitive advantage
- P/B ratio of 9.93x is extremely elevated, implying the stock prices in significant future growth with limited margin of safety
- P/E of 28.3x against a chemicals sector context demands continued high earnings delivery to justify valuation
- Potential capitalisation of interest costs raises accounting quality concerns and may overstate reported profitability
- Dividend yield of just 0.28% offers negligible income cushion during any market correction
- Debt-to-equity data is unavailable, making it difficult to fully assess balance sheet risk and leverage
- Market cap of ₹5,609 Cr for a niche chemical company implies rich expectations that may be vulnerable to commodity price cycles
- 10-year ROE average of 20% vs last year's 38% suggests recent returns may be cyclically inflated rather than structurally permanent
- 52-week high and low data unavailable, limiting visibility on recent price volatility and drawdown risk
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Stock split record date July 3 Jun 24
Krishana Phoschem set July 3, 2026 as record date for a 5:1 stock split, converting each Rs 10 share into five Rs 2 shares.
- New independent director appointed Jun 24
Archana Dangi regularised as Non-Executive Independent Director for a five-year term ending May 25, 2031.
- No promoter shares encumbered Jun 17
Krishana Phoschem disclosed zero promoter share encumbrance as of March 31, 2026, filed with NSE.
- Analyst virtual meet held Jun 16
Company held a virtual group meet on June 16, 2026 with no unpublished price sensitive information shared.
- Priyanka Surana exits board Jun 24
Priyanka Surana ceased as Independent Director on June 24, 2026 after completing her second term.
TL;DR: Recent newsflow for Krishana Phoschem is entirely procedural with no material positive or negative catalysts. The upcoming 5:1 stock split may improve retail liquidity, and zero promoter encumbrance signals clean promoter holding. No operational or financial updates have emerged, so the near-term outlook depends on upcoming quarterly results and commodity price trends in the phosphate/chemical space.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 165 | 265 | 230 | 263 | 281 | 301 | 304 | 473 | 396 | 608 | 659 | 755 | 532 |
| Expenses | 133 | 218 | 207 | 238 | 239 | 260 | 260 | 417 | 330 | 535 | 589 | 666 | 443 |
| Operating Profit | 32 | 47 | 24 | 26 | 42 | 40 | 44 | 56 | 66 | 73 | 70 | 89 | 89 |
| OPM % | 20% | 18% | 10% | 10% | 15% | 13% | 15% | 12% | 17% | 12% | 11% | 12% | 17% |
| Other Income | 1 | -1 | 0 | 1 | 1 | 2 | 2 | 6 | 3 | 3 | 4 | 5 | 6 |
| Interest | 7 | 10 | 9 | 11 | 12 | 10 | 9 | 8 | 9 | 7 | 9 | 14 | 21 |
| Depreciation | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 14 |
| PBT | 18 | 28 | 6 | 7 | 23 | 25 | 29 | 47 | 51 | 61 | 57 | 72 | 61 |
| Tax % | 33% | 32% | 41% | 17% | 28% | 32% | 29% | 30% | 40% | 45% | 41% | -15% | 22% |
| Net Profit | 12 | 19 | 4 | 6 | 16 | 17 | 21 | 33 | 31 | 33 | 33 | 83 | 47 |
| EPS in Rs | 0.4 | 0.62 | 0.12 | 0.18 | 0.53 | 0.54 | 0.66 | 1.06 | 0.99 | 1.07 | 1.08 | 2.69 | 1.52 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 89 | 80 | 96 | 146 | 162 | 188 | 318 | 323 | 923 | 1,355 | 2,418 | 2,555 |
| Expenses | 63 | 77 | 64 | 77 | 112 | 127 | 149 | 263 | 271 | 795 | 1,171 | 2,120 | 2,233 |
| Operating Profit | 10 | 12 | 15 | 19 | 33 | 35 | 39 | 56 | 52 | 128 | 184 | 298 | 322 |
| OPM % | 13% | 13% | 19% | 20% | 23% | 22% | 21% | 17% | 16% | 14% | 14% | 12% | 13% |
| Other Income | 4 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 3 | 2 | 10 | 16 | 19 |
| Interest | 5 | 5 | 4 | 6 | 3 | 3 | 2 | 4 | 7 | 37 | 39 | 39 | 50 |
| Depreciation | 3 | 6 | 6 | 8 | 11 | 12 | 10 | 10 | 9 | 34 | 31 | 34 | 40 |
| PBT | 5 | 3 | 6 | 6 | 19 | 21 | 28 | 43 | 39 | 59 | 123 | 241 | 250 |
| Tax % | 43% | 54% | 46% | 44% | 29% | 34% | 31% | 31% | 31% | 32% | 30% | 25% | — |
| Net Profit | 3 | 1 | 3 | 4 | 14 | 14 | 20 | 29 | 27 | 40 | 87 | 180 | 197 |
| EPS in Rs | 0.14 | 0.07 | 0.13 | 0.14 | 0.54 | 0.55 | 0.75 | 0.99 | 0.9 | 1.31 | 2.8 | 5.83 | 6.36 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 9% | 7% | 5% | 6% | 8% | 4% | 2% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 25 | 25 | 25 | 25 | 26 | 30 | 31 | 62 | 62 | 62 |
| Reserves | 52 | 59 | 68 | 71 | 85 | 100 | 121 | 191 | 231 | 239 | 322 | 499 |
| Borrowings | 30 | 32 | 46 | 42 | 32 | 12 | 21 | 70 | 276 | 436 | 376 | 733 |
| Other Liabilities | 19 | 5 | 14 | 11 | 29 | 21 | 27 | 39 | 44 | 108 | 276 | 347 |
| Total Liabilities | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,641 |
| Fixed Assets | 72 | 72 | 80 | 112 | 106 | 96 | 94 | 85 | 358 | 322 | 295 | 450 |
| CWIP | 9 | 8 | 25 | 0 | 1 | 0 | 7 | 92 | 3 | 43 | 78 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 42 | 37 | 48 | 37 | 64 | 62 | 94 | 153 | 220 | 479 | 664 | 1,189 |
| Total Assets | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,641 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 10 | 8 | 14 | 25 | 18 | 23 | 10 | -5 | -33 | -83 | 154 | -191 |
| Investing | -11 | -3 | -31 | -15 | -5 | -1 | -19 | -84 | -190 | -37 | -32 | -116 |
| Financing | 1 | -5 | 17 | -9 | -13 | -21 | 9 | 89 | 223 | 121 | -110 | 316 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 9 |
| Free Cash Flow | -1 | 4 | -16 | 9 | 13 | 21 | -12 | -91 | -226 | -121 | 116 | -305 |
| CFO/OP | 116 | 72 | 105 | 138 | 68 | 77 | 43 | 17 | -51 | -57 | 95 | -50 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24 | 62 | 66 | 52 | 53 | 41 | 54 | 60 | 84 | 104 | 102 | 108 |
| Inventory Days | 290 | 97 | 224 | 127 | 157 | 135 | 145 | 103 | 194 | 84 | 60 | 65 |
| Days Payable | 115 | 20 | 94 | 43 | 85 | 22 | 41 | 39 | 16 | 35 | 67 | 47 |
| Cash Conversion Cycle | 200 | 139 | 195 | 136 | 126 | 154 | 158 | 124 | 263 | 154 | 95 | 126 |
| Working Capital Days | 36 | 49 | 57 | 22 | 52 | 87 | 95 | 95 | 64 | 44 | 42 | 40 |
| ROCE % | 11% | 7% | 8% | 9% | 16% | 17% | 20% | 20% | 11% | 15% | 22% | 27% |
Documents
Frequently Asked Questions about Krishana Phoschem Ltd
What does Krishana Phoschem Ltd do?
Where is Krishana Phoschem Ltd (KRISHANA) listed?
Which sector does Krishana Phoschem Ltd belong to?
What is the market capitalisation of Krishana Phoschem Ltd?
What is the PE ratio of Krishana Phoschem Ltd?
What is the 52-week high and low of Krishana Phoschem Ltd?
Does Krishana Phoschem Ltd pay dividends?
What is the Return on Equity (ROE) of Krishana Phoschem Ltd?
How can I research Krishana Phoschem Ltd on Tapetide?
Company Information
Incorporated in 2004, Krishana Phoschem Ltd is in the business of manufacturing fertilisers & chemicals.[1] It manufactures and markets fertilisers under the brands ‘Annadata’ (SSP) and ‘Bharat’ (NPK/DAP complex).[2]